OLR1 and prostate carcinoma: Previous studies have shown that LOX-1 is highly expressed in gastric and prostate cancers and other tumor tissues, thereby promoting the proliferation, migration, and invasion of tumor cells and enhancing tumor angiogenesis and lymph node metastasis [23–25].